Iboga Experience Report: Hannah shares her microdosing experiences

Iboga is a plant from Central Africa, whose root bark has been used for centuries by the Bwiti culture in traditional ceremonies.

Its main active ingredient, ibogaine, is considered a psychedelic and has also been investigated in modern research for several years – primarily for its potential in mental health challenges such as depression, addiction, PTSD or exhaustion.

In very low doses, known as microdosing, users report a gentle, stabilizing effect on mood and concentration – without the intense, visionary experiences that can occur at higher doses, typical of a "drug trip".

In this Iboga experience report, graphic designer Hannah (32) tells us how she found a new path to more inner calm and emotional balance with the help of Iboga microdosing. After recurring low moods and lack of motivation, she sought a natural way to improve her well-being – and began to cautiously explore the effects of Iboga.

In this article, Hannah shares her individual experiences with Iboga microdosing.

Enjoy reading!

Note: All described content is based on scientific sources or subjective experience reports and is not to be understood as instructions or recommendations for the consumption of Iboga.

Over the last ten years, the African shrub Tabernanthe iboga has increasingly attracted the interest of Western scientists and pharmacologists, leading to a multitude of studies. The plant's most important active ingredient, the alkaloid ibogaine, proved to be a useful tool in the fight against addictions and dependencies on, for example, alcohol, nicotine, or opioids as early as the 1960s: By reducing drug cravings, it eases withdrawal for those affected.

Recent data from a series of studies suggest that controlled doses of ibogaine in medical settings could also help people with depression, post-traumatic stress disorder (PTSD), or bipolar disorder alleviate their symptoms. Scientific tests on animals have also shown pain-relieving effects.

Despite these promising scientific results, ibogaine is currently not approved as a medicine in Germany, which means that medical or therapeutic personnel are not allowed to prescribe or administer the substance. However, professional support would be desirable, as Iboga can pose risks, especially for people with heart problems or when certain medications are consumed simultaneously.

Microdosing refers to the regular intake of very small amounts of a psychoactive substance – so small that no hallucinogenic or strongly consciousness-altering effects occur. The goal is not to get "high", but to promote subtle, positive changes in everyday life – such as increased focus, creativity, emotional balance, or inner clarity. The typical "trips" associated with highdosing are absent.

Originally, microdosing was primarily associated with psychedelics such as LSD or psilocybin, but it is now also being explored with other natural substances like Iboga.

“My name is Hannah, I am 32 years old and I work as a graphic designer in a medium-sized company. My work is creative, but often stressful – especially when multiple deadlines are due simultaneously. Since the Corona era with its lockdowns, I have repeatedly experienced phases of mood swings or mild depressive episodes – not so severe that I couldn't function at all, but enough to often feel exhausted and overwhelmed. I no longer wanted to take medication, so I began to explore natural and herbal options to complement my psychotherapy. I wanted to take matters into my own hands and do something about my problem myself.”

“For several years, I have been dealing with mindfulness, psychotherapy, and alternative approaches to better manage my mental health. On a website, I came across an article about the Tabernanthe iboga shrub and current studies on its active ingredient ibogaine. Scientists use it, for example, in the treatment of addicts or to support the healing of depression or trauma in the brains of veterans. I had heard about "psychedelic therapies" before, but Iboga sounded particularly exciting in its depth and intensity, also because of its long history. Could this remedy perhaps also be of help to me?”

“After thorough research and consultation with an experienced therapist, I decided to try it cautiously – purely for research purposes and in very low doses.

Already in the first few days, I noticed subtle but interesting changes. I felt a bit more awake, more focused, and at the same time more internally calm. It was as if a quiet fog had lifted, without my consciousness actually changing. In moments where I would otherwise have fallen into rumination loops, I could think more clearly and better categorize my emotions.

After several weeks of microdosing, with breaks between intakes, I felt that my mood stabilized. I wasn't super happy or euphoric, but more present and more centered. My sleep quality also improved slightly. Of course, it wasn't a miracle cure – difficult days still existed, but I felt better able to handle them.”

"What I learned from this experience: Iboga microdosing can be an interesting tool for self-reflection, but of course, it's not a substitute for therapy and not an easy way out. Precisely because the substance can be potent and is legally and health-wise complex, one should approach it with great respect, knowledge, and caution.

For me personally, it was a valuable experience – not spectacular, but profound. A small step towards clarity and self-care. No question: I don't regret having taken this step."

Studies provide evidence that iboga can help people cope better with the symptoms of their mental illnesses and the associated burdens under certain circumstances. According to scientific data, iboga can also play an important role in the therapy of addictive disorders.

There is hope that iboga and its main active ingredient ibogaine will continue to be scientifically researched and eventually find use as a legal medicine in the context of medical and therapeutic treatments to make life easier for those affected by their illness.

Until then, user reports offer interesting insights into how iboga can affect people and their daily lives.

• Cherian, K.N., Keynan, J.N., Anker, L. et al. (2024). Magnesium–ibogaine therapy in veterans with traumatic brain injuries. Nat Med 30, 373–381 (2024). https://doi.org/10.1038/s41591-023-02705-w

• Fernandes-Nascimento, M. H., Viana-Ferreira, K., Rasmussen Chaves, B. D., Brooking Negrão, A., Wang, Y.-P. (2022). Ibogaine microdosing in a patient with bipolar depression: a case report. Braz J Psychiatry. 2022 Jul 15;44(4):462–463. doi: 10.47626/1516-4446-2021-2359

• Forsyth, B. , Machado, L., Jowett, T., Jakobi, H., Garbe, K., Winter, H., Glue, P. (2016). Effects of low dose ibogaine on subjective mood state and psychological performance. Journal of Ethnopharmacology. Volume 189, 2 August 2016, Pages 10-13. https://doi.org/10.1016/j.jep.2016.05.022

• Cherian K., Shinozuka K., Tabaac B.J., Arenas A., Beutler B.D., Evans V.D., Fasano C., Muir O.S. (2024). Psychedelic Therapy: A Primer for Primary Care Clinicians-Ibogaine. Am J Ther. 2024 Mar-Apr 01;31(2):e133-e140. doi:10.1097/MJT.0000000000001723